2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Oral Session

[O5] Oral Session 5 Breast Cancer
【E】

Thu. Feb 17, 2022 4:00 PM - 5:30 PM Room 10 (Royal Room, 1F, The Prince Kyoto Takaragaike)

Chair:Masakazu Toi(Graduate School of Medicine, Kyoto University Hospital),Yutaka Yamamoto(Department of Breast and Endocrine Surgery, Kumamoto University Hospital)
Discussant:Shigenori Nagai(Department of Breast Oncology, Saitama Cancer Center)

Tetsuhiro Yoshinami1,10, Norikazu Masuda2, Masahiko Ikeda3, Makiko Mizutani2, Miki Yamaguchi4, Yoshifumi Komoike5, Tsutomu Takashima6, Katsuhide Yoshidome7, Junji Tsurutani8, Mitsuhiko Iwamoto9, Fumie Fujisawa10, Hiroyuki Yasojima2, Jun Yamamura11, Hirotaka Morishima12, Fuminori Aki13, Tomomi Yamada14, Satoshi Morita15, Takahiro Nakayama16 (1.Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, 2.Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, 3.Department of Breast and Thyroid Surgery, Fukuyama City Hospital, 4.Department of Breast Surgery, JCHO Kurume General Hospital, 5.Department of Medicine, Kindai University Hospital, 6.Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka City University, 7.Department of Breast and Endocrine Surgery, Osaka Police Hospital, 8.Advanced Cancer Translation Research Institute, Showa University, 9.Breast and Endocrine Surgery, Osaka Medical College, 10.Department of Medical Oncology, Osaka International Cancer Institute, 11.Department of Surgery, Sakai City Medical Center, 12.Department of Breast Surgery, Osaka Rosai Hospital, 13.Ito Surgical Mammary Gland Clinic, 14.Department of Medical Innovation, Osaka University Hospital, 15.Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 16.Department of Breast and Endocrine Surgery, Osaka International Cancer Institute)

Haruru Kotani1, Kenji Tamura2, Toru Mukohara3, Kan Yonemori4, Yumiko Kawabata5, Xavier Nicolas6, Tomoyuki Tanaka5, Hiroji Iwata1 (1.Aichi Cancer Center Hospital, Aichi, Japan, 2.Shimane University Hospital, Shimane, Japan, 3.National Cancer Center Hospital East, Kashiwa, Japan, 4.National Cancer Center Hospital, Tokyo, Japan, 5.Sanofi, Tokyo, Japan, 6.Sanofi, Montpellier, France)

Masaya Hattori1, Yoichi Naito3, Yamanaka Takashi4, Yasoshima Hiroyuki5, Miyaki Toshiko6, Watanabe Junichiro7, Yoshinami Tetsuhiro8, Ozaki Yukinori9, Nakamura Yoshiaki3, Bando Hideaki3, Yamaguchi Rui2, Imoto Issei2, Yoshino Takayuki3, Iwata Hiroji1 (1.Department of Breast Oncology, Aichi Cancer Center, 2.Aichi Cancer Center Research Institute, 3.National Cancer Center Hospital East, 4.Kanagawa Cancer Center, 5.National Hospital Organization Osaka National Hospital, 6.Chiba Cancer Center, 7.Div. Breast Oncology, Shizuoka Cancer Center, 8.Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, 9.Department of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research)

Ryan Ying Cong Tan1, Whee Sze Ong2, Kyung-Hun Lee3, Abner Lim4, Makiko Ono5, Takayuki Ueno6, Yoichi Naito7, Tatsuya Onishi8, Geok-Hoon Lim9,10, Su-Ming Tan10,11, Ching-Hung Lin12, Yen-Shen Lu12, Seri Park13, Yeon-Hee Park13,14, Veronique Kiak Mien Tan10,15,16, Fuh-Yong Wong17, Seock-Ah Im3, Puay Hoon Tan18, Jason Yong Sheng Chan1, Yoon-Sim Yap1 (1.Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 2.Biostatistics Unit, Clinical Trials & Epidemiological Sciences, National Cancer Centre Singapore, Singapore, 3.Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea, 4.Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore, Singapore, 5.Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, 6.Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, 7.Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan, 8.Department of Breast Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan, 9.Breast Department, KK Women's and Children's Hospital, Singapore, 10.SingHealth Duke-NUS Breast Centre, Singapore, 11.Division of Breast Surgery, Department of General Surgery, Changi General Hospital, Singapore, 12.Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, 13.Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of South Korea, 14.Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of South Korea, 15.Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, 16.Department of Breast Surgery, Singapore General Hospital, Singapore, 17.Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, 18.Division of Pathology, Singapore General Hospital, Singapore)

Toshinari Yamashita1, Shanu Modi2, Ian Krop3, Yeon Hee Park4, Sung-Bae Kim5, Kenji Tamura6, Fabrice Andre7, Hiroji Iwata8, Yoshinori Ito9, Junji Tsurutani10, Joohyuk Sohn11, Caleb Lee12, Yali Liu12, Jillian Cathcart12, Jasmeet Singh12, Cristina Saura13 (1.Kanagawa Cancer Center, Kanagawa, Japan, 2.Memorial Sloan Kettering Cancer Center, New York, NY, USA, 3.Dana-Farber Cancer Institute, Boston, MA, USA, 4.Samsung Medical Center, Seoul, South Korea, 5.Asan Medical Center, Seoul, South Korea, 6.Shimane University Hospital, Shimane, Japan, 7.Gustave Roussy, Villejuif, France, 8.Aichi Cancer Center Hospital, Aichi, Japan, 9.Nippon Medical School, Tokyo, Japan, 10.Showa University, Tokyo, Japan, 11.Yonsei Cancer Center, Seoul, South Korea, 12.Daiichi Sankyo, Inc., Basking Ridge, NJ, USA, 13.Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)